TSS
RCKT icon

Two Sigma Securities’s Rocket Pharmaceuticals RCKT Stock Holding History

Two Sigma Securities’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,038
Closed -$42.3K – 2109
2025
Q4 		$42.3K Buy
+12,038
New +$41.2K 0.01% 1092
2025
Q3 		– Sell
-12,759
Closed -$31.3K – 1897
2025
Q2 		$31.3K Buy
+12,759
New +$64.6K ﹤0.01% 1148

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Two Sigma Securities's RCKT Position: Q1 2026 in Review

Two Sigma Securities sold out of Rocket Pharmaceuticals (RCKT) in Q1 2026, closing a stake of 12,038 shares — an estimated $42.3K sold.

Two Sigma Securities first reported a position in RCKT in Q2 2025 and held it in 2 quarters. The position peaked at $42.3K in Q4 2025. 198 funds tracked by Wall St. Rank hold RCKT as of Q1 2026.

  • Two Sigma Securities reported no remaining Rocket Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 12,038 Rocket Pharmaceuticals shares in Q1 2026, an estimated $42.3K.
  • Two Sigma Securities first reported a position in Rocket Pharmaceuticals in Q2 2025 and held it in 2 quarters.
  • Two Sigma Securities's Rocket Pharmaceuticals position peaked at $42.3K in Q4 2025.
  • 198 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.